B-Cell Maturation Antigen (BCMA) Targeted Therapies Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

Multiple myeloma is an incurable disease of plasma cells, which needs some intervention by clinical researchers. However, there have been recent success in developing such therapy that can be effective in hematologic malignancies such as chimeric antigen receptor CAR-T cell therapy, which is expected to be promising in cancer treatment. However, researchers have found little success in finding a specific target antigen under CAR T-cell therapies for treating multiple myeloma. Though, there have been recent studies that suggest a targeted effect of B-cell maturation antigen (BCMA) that has been effective in cells with multiple myelomas. BCMA is a protein, which is selectively expressed by B-lineage cells that directly work on cells with multiple myelomas. Researchers are still working to determine the compatibility in target for CAR-expressing T cells for BCMA. Furthermore, B-cell maturation antigen (BCMA) is a vital biomarker of the B-cells that is a promising and newly emerged therapeutic target to treat multiple myeloma and other hematological malignancies.

Multiple myeloma affected cells are considered to be having B-cell maturation antigen. This has led to various studies related to BCMA targeted therapies in the recent past. Multiple myeloma is the second-most common type of hematological malignancy, which affects a large population. According to the American Cancer Society, in 2017, around 30,280 new cases are estimated to be diagnosed, leading to around 2,600 deaths. Middle-aged men exposed to any type of radiation or chemicals a past history of monoclonal gammopathy of undetermined significance (MGUS) are most at risk of contracting multiple myeloma. Increasing awareness among the research community and renewed efforts across the globe to effectively treat cancer and related diseases is expected to provide major traction for growth of the BCMA targeted therapies market in the foreseeable future.

BCMA Targeted Therapies Market Taxonomy:

By Product Type

  • CAR-T cells
  • Bispecific Antibodies
  • Antibody Drug Conjugates

By End User

  • Hospitals
  • Cancer Research Institutes


Increase in prevalence of multiple myeloma globally is expected to support growth of BCMA targeted therapies market:

Multiple myeloma can be fatal and is linked with frequent events of re-occurrence of the disorder along various other serious complications associated with it. The globally widespread prevalence of the disorder and B-cell malignancies needs specific and targeted diagnosis and treatments. Hence, there is an immediate requirement for targeted and effective therapies to provide appropriate medical care. This in turn is expected to favor growth of BCMA market in the near future. Multiple myeloma is characterized by the clonal proliferation of plasma cells in bone marrow, which leads to bone destruction, renal abnormalities, anemia and hypercalcemia. The rise in prevalence of multiple myelomas in the population around the globe is projected to underpin the growth expansion of targeted therapies in BCMA market in the near future. According to National Institutes of Health and National Cancer Institute, in 2013, in the U.S., there were around 96,000 people living with myeloma.

Specificity and targeted effect on cancer cells is projected to favor growth of the BCMA targeted therapies market

B cell maturation antigen, is the member of the tumor necrosis factor receptor group and a type III membrane protein containing one extracellular cysteine rich domain, which has been designated as TNFRSF17. The specificity of the therapy to treat the patients affected from multiple myelomas is projected to be one of the vital factors favoring growth in adoption of B-Cell Maturation Antigen targeted therapies in the near future. Furthermore, collaboration between the existing players in the B-Cell Maturation Antigen market is expected to be one of the crucial factor in its growth, this will further expected to enhance the company’s product portfolio over the forecast period.

Key players operating in the BCMA targeted therapies market include Celgene Corporation, bluebird bio, Poseida Therapeutics, Inc., Juno Therapeutics, Eureka Therapeutics,

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.